Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-007706
Filing Date
2025-02-25
Accepted
2025-02-25 15:43:32
Documents
1
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740516204.html 4  
1 FORM 4 wk-form4_1740516204.xml 4 3339
  Complete submission text file 0001628280-25-007706.txt   4850
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Issuer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address
HANLY ANN M. (Reporting) CIK: 0001854528 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 25662787